CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
56.55
0.25%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.17
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026207 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026207%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003985 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003985%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Vaxcyte Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 56.69
Open* 55.73
1-Year Change* 29.06%
Day's Range* 55.73 - 56.99
52 wk Range 34.11-54.97
Average Volume (10 days) 573.21K
Average Volume (3 months) 12.40M
Market Cap 4.83B
P/E Ratio -100.00K
Shares Outstanding 95.15M
Revenue N/A
EPS -3.30
Dividend (Yield %) N/A
Beta 0.86
Next Earnings Date Feb 26, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 8, 2023 56.55 -0.18 -0.32% 56.73 57.09 55.65
Dec 7, 2023 56.69 0.48 0.85% 56.21 57.35 55.27
Dec 6, 2023 56.19 2.26 4.19% 53.93 56.29 52.85
Dec 5, 2023 53.62 -0.33 -0.61% 53.95 54.86 53.13
Dec 4, 2023 54.09 0.97 1.83% 53.12 54.92 52.63
Dec 1, 2023 53.78 2.82 5.53% 50.96 53.80 50.51
Nov 30, 2023 51.73 2.05 4.13% 49.68 52.46 49.28
Nov 29, 2023 49.63 0.21 0.42% 49.42 51.05 49.42
Nov 28, 2023 50.00 0.84 1.71% 49.16 50.02 48.71
Nov 27, 2023 50.05 2.10 4.38% 47.95 50.27 47.95
Nov 24, 2023 49.17 0.71 1.47% 48.46 49.94 48.01
Nov 22, 2023 48.91 -2.07 -4.06% 50.98 50.99 48.64
Nov 21, 2023 50.71 1.67 3.41% 49.04 51.65 49.04
Nov 20, 2023 51.32 0.99 1.97% 50.33 51.90 50.33
Nov 17, 2023 51.38 2.55 5.22% 48.83 51.66 48.83
Nov 16, 2023 50.04 0.53 1.07% 49.51 51.04 49.51
Nov 15, 2023 50.74 2.75 5.73% 47.99 51.66 47.99
Nov 14, 2023 49.50 0.60 1.23% 48.90 50.83 48.90
Nov 13, 2023 48.33 1.49 3.18% 46.84 48.76 46.10
Nov 10, 2023 48.07 0.05 0.10% 48.02 48.38 46.67

Vaxcyte, Inc. Events

Time (UTC) Country Event
Monday, February 26, 2024

Time (UTC)

21:00

Country

US

Event

Q4 2023 Vaxcyte Inc Earnings Release
Q4 2023 Vaxcyte Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0 0 0 0 0
Total Operating Expense 232.3 103.67 89.581 54.153 35.533
Selling/General/Admin. Expenses, Total 73.586 42.735 16.017 8.546 5.388
Research & Development 135.675 60.935 73.564 45.607 30.145
Operating Income -232.3 -103.67 -89.581 -54.153 -35.533
Interest Income (Expense), Net Non-Operating 6.884 2.008 -2.114 0.457 0.87
Other, Net 1.931 1.585 2.478 3.422 5.178
Net Income Before Taxes -223.485 -100.077 -89.217 -50.274 -29.485
Net Income After Taxes -223.485 -100.077 -89.217 -50.274 -29.485
Net Income Before Extra. Items -223.485 -100.077 -89.217 -50.274 -29.485
Net Income -223.485 -100.077 -89.217 -50.274 -29.485
Income Available to Common Excl. Extra. Items -223.485 -100.077 -89.217 -50.274 -29.485
Income Available to Common Incl. Extra. Items -223.485 -100.077 -89.217 -50.274 -29.485
Diluted Net Income -223.485 -100.077 -89.217 -50.274 -29.485
Diluted Weighted Average Shares 64.878 51.9221 29.5458 48.3858 48.3858
Diluted EPS Excluding Extraordinary Items -3.4447 -1.92744 -3.01962 -1.03902 -0.60937
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -3.08958 -1.92744 -3.00946 -1.03902 -0.60937
Unusual Expense (Income) 23.039
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 0 0 0 0 0
Total Operating Expense 87.147 71.192 86.617 58.577 47.886
Selling/General/Admin. Expenses, Total 14.456 26.093 23.334 19.855 16.623
Research & Development 72.691 45.099 40.244 38.722 31.263
Operating Income -87.147 -71.192 -86.617 -58.577 -47.886
Interest Income (Expense), Net Non-Operating 16.344 10.076 7.642 0.503 -1.336
Other, Net 2.464 0.654 0.925 0.157 0.69
Net Income Before Taxes -68.339 -60.462 -78.05 -57.917 -48.532
Net Income After Taxes -68.339 -60.462 -78.05 -57.917 -48.532
Net Income Before Extra. Items -68.339 -60.462 -78.05 -57.917 -48.532
Net Income -68.339 -60.462 -78.05 -57.917 -48.532
Income Available to Common Excl. Extra. Items -68.339 -60.462 -78.05 -57.917 -48.532
Income Available to Common Incl. Extra. Items -68.339 -60.462 -78.05 -57.917 -48.532
Diluted Net Income -68.339 -60.462 -78.05 -57.917 -48.532
Diluted Weighted Average Shares 98.0579 86.2068 79.0122 61.9893 60.8188
Diluted EPS Excluding Extraordinary Items -0.69693 -0.70136 -0.98782 -0.93431 -0.79798
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.69693 -0.70136 -0.69623 -0.93431 -0.79798
Unusual Expense (Income) 23.039
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 942.555 256.348 389.004 61.723 66.668
Cash and Short Term Investments 931.376 245.97 386.2 58.976 66.09
Cash & Equivalents 834.657 68.985 386.2 58.976 66.09
Prepaid Expenses 11.179 10.378 2.804 2.747 0.578
Total Assets 1006.18 324.337 392.826 65.698 70.802
Property/Plant/Equipment, Total - Net 31.648 35.912 3.272 3.391 3.411
Property/Plant/Equipment, Total - Gross 37.765 39.46 7.369 6.373 5.162
Accumulated Depreciation, Total -6.117 -3.548 -4.097 -2.982 -1.751
Other Long Term Assets, Total 5.426 4.96 0.55 0.584 0.723
Total Current Liabilities 40.525 28.716 46.861 11.052 6.713
Accounts Payable 9.795 6.758 29.785 3.376 2.83
Accrued Expenses 30.73 21.958 17.062 7.657 3.88
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0 0.014 0.019 0.003
Total Liabilities 52.565 40.319 46.983 11.761 10.72
Total Long Term Debt 0 0 0 0.45 3.647
Long Term Debt 0.45 3.647
Other Liabilities, Total 12.04 11.603 0.122 0.259 0.36
Total Equity 953.613 284.018 345.843 53.937 60.082
Redeemable Preferred Stock 160.31 117.81
Common Stock 0.082 0.056 0.054 0.007 0.006
Additional Paid-In Capital 1476.02 582.844 544.353 2.967 1.339
Retained Earnings (Accumulated Deficit) -522.126 -298.641 -198.564 -109.347 -59.073
Total Liabilities & Shareholders’ Equity 1006.18 324.337 392.826 65.698 70.802
Total Common Shares Outstanding 79.4707 53.032 51.0716 48.3858 48.3858
Short Term Investments 96.719 176.985
Long Term Investments 26.549 27.117
Other Equity, Total -0.361 -0.241
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 1295.43 1310.32 840.674 942.555 369.759
Cash and Short Term Investments 1265.68 1287.06 822.038 931.376 362.226
Cash & Equivalents 545.134 531.033 380.451 834.657 278.401
Short Term Investments 720.55 756.031 441.587 96.719 83.825
Prepaid Expenses 29.75 23.253 18.636 11.179 7.533
Total Assets 1496.06 1502.82 1008.16 1006.18 412.065
Property/Plant/Equipment, Total - Net 27.764 34.426 34.863 31.648 32.834
Property/Plant/Equipment, Total - Gross 36.148 42.005 41.691 37.765 38.249
Accumulated Depreciation, Total -8.384 -7.579 -6.828 -6.117 -5.415
Long Term Investments 168.564 153.726 127.815 26.549 3.977
Other Long Term Assets, Total 4.295 4.35 4.811 5.426 5.495
Total Current Liabilities 85.558 60.216 52.747 40.525 39.309
Accounts Payable 15.704 16.266 11.615 9.795 5.485
Accrued Expenses 69.854 43.95 41.132 30.73 33.824
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total
Total Liabilities 93.341 69.443 63.392 52.565 52.754
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 7.783 9.227 10.645 12.04 13.445
Total Equity 1402.72 1433.38 944.771 953.613 359.311
Redeemable Preferred Stock 0
Common Stock 0.098 0.097 0.084 0.082 0.064
Additional Paid-In Capital 2148.5 2086.73 1527.23 1476.02 803.98
Retained Earnings (Accumulated Deficit) -743.591 -650.927 -582.588 -522.126 -444.076
Other Equity, Total -2.29 -2.521 0.047 -0.361 -0.657
Total Liabilities & Shareholders’ Equity 1496.06 1502.82 1008.16 1006.18 412.065
Total Common Shares Outstanding 93.8469 93.8125 80.6408 79.4707 60.5727
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -223.485 -100.077 -89.217 -50.274 -29.485
Cash From Operating Activities -170.597 -121.393 -46.628 -47.145 -30.466
Cash From Operating Activities 2.577 1.8 1.405 1.232 1.037
Non-Cash Items 37.574 13.889 5.914 -2.011 -3.913
Cash Interest Paid 0.002 0.007 0.007 0.04 0.075
Changes in Working Capital 12.737 -37.005 35.27 3.908 1.895
Cash From Investing Activities 74.585 -212.308 -1.105 -1.195 -1.773
Capital Expenditures -5.848 -6.555 -1.155 -1.195 -1.774
Other Investing Cash Flow Items, Total 80.433 -205.753 0.05 0 0.001
Cash From Financing Activities 861.547 17.796 374.87 41.567 62.19
Issuance (Retirement) of Stock, Net 862.408 17.796 378.299 42.942 62.473
Issuance (Retirement) of Debt, Net 0 0 -0.061 -0.278 -0.283
Net Change in Cash 765.672 -316.344 327.224 -7.114 29.951
Financing Cash Flow Items -0.861 0 -3.368 -1.097 0
Foreign Exchange Effects 0.137 -0.439 0.087 -0.341 0
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -60.462 -223.485 -145.435 -87.518 -38.986
Cash From Operating Activities -47.69 -170.597 -105.376 -66.828 -27.702
Cash From Operating Activities 0.712 2.577 1.875 1.191 0.582
Non-Cash Items 5.288 37.574 22.147 14.067 6.308
Cash Interest Paid 0 0.002 0.002 0.002 0
Changes in Working Capital 6.772 12.737 16.037 5.432 4.394
Cash From Investing Activities -448.101 74.585 110.537 75.831 49.666
Capital Expenditures -5.609 -5.848 -4.701 -3.858 -2.92
Other Investing Cash Flow Items, Total -442.492 80.433 115.238 79.689 52.586
Cash From Financing Activities 41.562 861.547 204.914 160.897 111.019
Financing Cash Flow Items -0.727 -0.861 106.763 107.624 107.622
Issuance (Retirement) of Stock, Net 42.289 862.408 98.151 53.273 3.397
Issuance (Retirement) of Debt, Net 0
Foreign Exchange Effects 0.023 0.137 -0.659 -0.712 -0.227
Net Change in Cash -454.206 765.672 209.416 169.188 132.756
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Fidelity Management & Research Company LLC Investment Advisor 13.6096 12772235 1751381 2023-06-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.7625 8223374 1702373 2023-06-30 LOW
RA Capital Management, LP Hedge Fund 8.4086 7891254 600000 2023-06-30 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 7.5226 7059751 -67860 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.2986 5911023 1434267 2023-06-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 4.7217 4431211 1191937 2023-06-30 LOW
Capital Research Global Investors Investment Advisor 3.5847 3364127 511121 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.3707 3163312 87296 2023-06-30 LOW
Fred Alger Management, LLC Investment Advisor/Hedge Fund 2.5267 2371218 1526440 2023-06-30 MED
T. Rowe Price Associates, Inc. Investment Advisor 2.2909 2149944 2020413 2023-06-30 LOW
AllianceBernstein L.P. Investment Advisor/Hedge Fund 2.0119 1888106 1804718 2023-06-30 LOW
Braidwell LP Hedge Fund 1.8353 1722353 402375 2023-06-30 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.7957 1685214 355875 2023-06-30 LOW
Perceptive Advisors LLC Private Equity 1.72 1614122 444122 2023-06-30 MED
Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 1.5778 1480747 810663 2023-06-30 LOW
Jennison Associates LLC Investment Advisor/Hedge Fund 1.5499 1454502 24463 2023-06-30 LOW
Kynam Capital Management LP Hedge Fund 1.3852 1300000 83216 2023-06-30 MED
Fidelity Institutional Asset Management Investment Advisor 1.3682 1284001 496290 2023-06-30 LOW
Millennium Management LLC Hedge Fund 1.2937 1214072 -99570 2023-06-30 HIGH
Driehaus Capital Management, LLC Investment Advisor/Hedge Fund 1.2679 1189857 575951 2023-06-30 MED

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Vaxcyte, Inc. Company profile

About Vaxcyte Inc

Vaxcyte Inc. is a vaccine company, which is focused on developing vaccines designed to prevent or treat common and deadly infectious diseases worldwide. Its cell-free protein synthesis platform enables it to design and produce protein carriers and antigens. Its pipeline includes VAX-24, VAX-XP, VAX-A1 and VAX-PG. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine (PCV). The Company's second PCV candidate, VAX-XP, uses its modular platform and builds on the technical proof of concept established by VAX-24. VAX-A1 is a conjugate vaccine being developed for group A strep infections. Its VAX -PG is being developed as a protein vaccine for the treatment of periodontitis.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Vaxcyte Inc revenues was not reported. Net loss increased 12% to $100.1M. Higher net loss reflects General and administrative - Balancing increase of 49% to $18.5M (expense), Stock-based Compensation in SGA increase of 90% to $6.8M (expense), Stock-based Compensation in R&D increase from $1.9M to $4M (expense).

Industry: Bio Therapeutic Drugs

825 Industrial Road, Ste. 300
SAN CARLOS
CALIFORNIA 94070
US

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

BTC/USD

44,047.25 Price
-1.270% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,004.85 Price
-1.180% 1D Chg, %
Long position overnight fee -0.0198%
Short position overnight fee 0.0116%
Overnight fee time 22:00 (UTC)
Spread 0.50

Oil - Crude

71.41 Price
+2.320% 1D Chg, %
Long position overnight fee -0.0204%
Short position overnight fee -0.0015%
Overnight fee time 22:00 (UTC)
Spread 0.030

XRP/USD

0.68 Price
+0.260% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading